1
1 of 3
- Westerly Hospital35 Wells StreetSte Yale UrologyWesterly, RI 02891
- Yale UrologyLawrence + Memorial Hospital365 Montauk Avenue, Fl 2nd Floor Ste Suite 2.013New London, CT 06320
- Yale Urology176 Toll Gate RoadSte Suite 301Warwick, RI 02886
Joseph Renzulli, MD, FACS
Urology
MAKE AN APPOINTMENT ONLINELearn more about telehealth
Telehealth is available
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From physicians only
Board Certified in
Urology
Biography
Joseph F. Renzulli II MD, FACS, is a Yale Medicine urologist who has expertise in robotic-assisted and laparoscopic surgeries for treating urologic cancers such as prostate, bladder, and kidney cancer.
“The best part of my job is being able to offer patients cutting-edge surgical therapies right here in their own community,” Dr. Renzulli says, “so that they do not have to travel to distant medical centers and be away from their loved ones during their most stressful times.” For him, medicine is a calling. “Being able to help people in their most vulnerable times is something that I have always seen as an amazing responsibility, and I am privileged to be able to care for them,” he says. After a cancer diagnosis, Dr. Renzulli develops individualized treatment plans for his patients, which may include helping them find and enroll in open clinical trials. He also tries to ease anxiety.
“I tell patients to let me do the worrying for them. I have seen their situation before and can take care of it for them,” he says.
Titles
- Associate Professor of Urology
- Chief of Urology at Lawrence + Memorial Hospital, Urology, Lawrence + Memorial Hospital
- Chief of Urology at Westerly Hospital, Urology, Westerly Hospital
Education & Training
- Chief ResidentYale School of Medicine (2006)
- ResidentYale School of Medicine (2005)
- InternshipYale School of Medicine (2002)
- MDBoston University School of Medicine (2001)
- BABoston University, Biology (1997)
Additional Information
Board Certifications
- AB of Urology, Urology (2008)
Publications
- Ajjawi I, Sprenkle P, Renzulli J, Leapman M. Re-evaluating the Role of Locoregional Therapy in Metastatic Prostate Cancer: A Review of Current Evidence and Evolving Clinical Approaches. Urologic Clinics Of North America 2026 DOI: 10.1016/j.ucl.2026.02.002.
- Smani S, DuBois J, Ajjawi I, Sohoni N, Choksi A, Lokeshwar S, Kim I, Renzulli J. Advances in Current Treatment Paradigms for Metastatic Hormone-Sensitive Prostate Cancer. Journal Of Clinical Medicine 2025, 14: 2565. PMID: 40283395, PMCID: PMC12028174, DOI: 10.3390/jcm14082565.
- Kinnaird A, Luger F, Cash H, Ghai S, Urdaneta-Salegui LF, Pavlovich CP, Brito J, Shore ND, Struck JP, Schostak M, Harland N, Rodriguez-Socarrás M, Brisbane WG, Lughezzani G, Toledano H, Ouertani MS, Macek P, Fung C, Tu W, Gusenleitner A, Günzel K, Incze PF, George AK, Pereira JG, Jansen R, Renzulli J 2nd, Klotz L, OPTIMUM Investigators. Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial. JAMA 2025 PMID: 40121537, DOI: 10.1001/jama.2025.3579.
- Khajir G, Webb L, Lokeshwar S, Diaz G, Anderson T, Choksi A, Zhao J, Leapman M, Sprenkle P, Renzulli J. Diagnostic performance of high-resolution micro-ultrasound and conventional ultrasound in fusion biopsy for clinically significant prostate cancer detection. Urologic Oncology Seminars And Original Investigations 2025, 43: 399.e1-399.e8. PMID: 40121104, DOI: 10.1016/j.urolonc.2025.03.006.
- GC6 – Micro-ultrasound-guided versus MRI-guided biopsy for prostate cancer diagnosis (OPTIMUM trial)Klotz L, Luger F, Cash H, Schostak M, Ghai S, Pavlovich C, Urdaneta-Salegui L, Struck J, Renzulli J, Shore N, Gomez-Sancha F, Harland N, Brisbane W, Lughezzani G, Toledano H, Ouertani S, Macek P, Fung C, Gusenleitner A, Tu W, Kinnaird A. GC6 – Micro-ultrasound-guided versus MRI-guided biopsy for prostate cancer diagnosis (OPTIMUM trial). European Urology 2025, 87: s1794-s1795. DOI: 10.1016/j.eururo.2025.09.4123.
- Kim I, Leapman M, Kim M, Rahman S, Sprenkle P, Renzulli J, Brito J, Hyams E, Kim J, Pareek G, Kim I. Radical prostatectomy is associated with favorable outcomes in patients over 80 years old. American Journal Of Clinical And Experimental Urology 2025, 13: 33-42. PMID: 40124572, PMCID: PMC11928824, DOI: 10.62347/nkgs2301.
- Lokeshwar S, Choksi A, Smani S, Kong V, Sundaresan V, Sutherland R, Brito J, Renzulli J, Sprenkle P, Leapman M. Pathologic prostate cancer grade concordance among high-resolution micro-ultrasound, systematic transrectal ultrasound and MRI fusion biopsy. Urologic Oncology Seminars And Original Investigations 2024, 43: 336.e13-336.e20. PMID: 39521675, DOI: 10.1016/j.urolonc.2024.10.018.
- Smani S, Novosel M, Sutherland R, Jeong F, Jalfon M, Marks V, Rajwa P, Nolazco J, Washington S, Renzulli J, Sprenkle P, Kim I, Leapman M. Association between sociodemographic factors and diagnosis of lethal prostate cancer in early life. Urologic Oncology Seminars And Original Investigations 2023, 42: 28.e9-28.e20. PMID: 38161105, DOI: 10.1016/j.urolonc.2023.10.005.
- Shore N, Renzulli J, Fleshner N, Hollowell C, Vourganti S, Silberstein J, Siddiqui R, Hairston J, Elsouda D, Russell D, Cooperberg M, Tomlins S. MP62-17 ENZALUTAMIDE IN PATIENTS WITH LOCALIZED PROSTATE CANCER UNDERGOING ACTIVE SURVEILLANCE: ENACT. Journal Of Urology 2021, 206: e1099-e1099. DOI: 10.1097/ju.0000000000002102.17.
- Ross A, Armstrong A, Pieczonka C, Bailen J, Tutrone R, Cooperberg M, Pavlovich C, Renzulli J, Haynes H, Sheikh N, Shore N. A comparison of sipuleucel-T (sip-T) product parameters from two phase III studies: PROVENT in active surveillance prostate cancer and IMPACT in metastatic castrate-resistant prostate cancer (mCRPC). Journal Of Clinical Oncology 2020, 38: 321-321. DOI: 10.1200/jco.2020.38.6_suppl.321.
- Pereira J, Gershman B, Renzulli J. PD52-03 THE ASSOCIATION OF EDUCATION LEVEL WITH THE UTILIZATION OF SHARED DECISION MAKING IN PROSTATE CANCER SCREENING. Journal Of Urology 2018, 199: e981-e982. DOI: 10.1016/j.juro.2018.02.2355.
- Pereira J, Pareek G, Golijanin D, Renzulli J, Gershman B. MP14-05 THE ASSOCIATION OF AGE WITH PERIOPERATIVE MORBIDITY AND MORTALITY AMONG PATIENTS UNDERGOING RADICAL PROSTATECTOMY. Journal Of Urology 2017, 197: e163-e164. DOI: 10.1016/j.juro.2017.02.469.
- Pereira J, Shillan H, Tucci C, Pareek G, Golijanin D, Gershman B, Renzulli J. MP97-13 ASSOCIATION OF EXTENDED PELVIC LYMPH NODE DISSECTION WITH THROMBOEMBOLIC EVENTS AND LYMPHOCELE FORMATION AMONG MEN UNDERGOING ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY WITH PELVIC LYMPH NODE DISSECTION. Journal Of Urology 2017, 197: e1308. DOI: 10.1016/j.juro.2017.02.3057.
- Turini G, Renzulli J. MP92-19 NOVEL, NONTOXIC SKIN CARE FORMULATION ASSOCIATED WITH LOWER CAUTI RATES FOR HIGH-RISK ICU, NEURO, C-V AND TRAUMA PATIENTS WHEN USED FOR FOLEY CATHETER INSERTION AND MAINTENANCE. Journal Of Urology 2017, 197: e1235. DOI: 10.1016/j.juro.2017.02.2880.
- Pereira J, Renzulli J, Pareek G, Moreira D, Golijanin D, Gershman B. 781 Perioperative morbidity of open versus minimally invasive partial nephrectomy: A contemporary analysis of the National Surgical Quality Improvement Program (NSQIP). European Urology Open Science 2017, 16: e1352-e1353. DOI: 10.1016/s1569-9056(17)30834-5.
- Turini G, Clark M, Machan J, Tucci C, Renzulli J. The Role of a Standardized Clinical Care Pathway in Patient Satisfaction and Quality of Life Outcomes after Robotic Assisted Laparoscopic Radical Prostatectomy. Urology Practice 2016, 4: 232-238. PMID: 37592643, DOI: 10.1016/j.urpr.2016.06.006.
- Leone A, Diorio G, Brito J, Zargar K, Pareek G, Renzulli J, Dickinson S, Amin A, Sexton W, Spiess P, Poch M, Golijanin D. Presence and percentage of type 2 papillary RCC in mixed (type 1 and type 2) papillary renal cell carcinoma does not portend worse prognosis in patients treated by partial/radical nephrectomy in non-metastatic disease. Journal Of Clinical Oncology 2016, 34: e16126-e16126. DOI: 10.1200/jco.2016.34.15_suppl.e16126.
- Turini G, Gjelsvik A, Golijanin D, Pareek G, Renzulli J. PD09-07 THE ROLE OF PATIENT RACE AND ETHNICITY IN PREDICTING PHYSICIAN RECOMMENDATION OF PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING. Journal Of Urology 2016, 195: e236. DOI: 10.1016/j.juro.2016.02.2902.
- Turini G, Clark M, Tucci C, Machan J, Golijanin D, Pareek G, Renzulli J. MP08-05 REDUCED LENGTH OF STAY AND READMISSION RATES USING A STANDARDIZED CLINICAL CARE PATHWAY FOLLOWING ROBOTIC PROSTATECTOMY. Journal Of Urology 2016, 195: e86. DOI: 10.1016/j.juro.2016.02.2250.
- Brito J, Rotker K, Lepe M, Quddus M, Manna P, Epstein J, Matoso A, Renzulli J. MP36-18 HIGH-RISK HPV SUBTYPES IN SQUAMOUS CELL CARCINOMA OF THE SCROTUM. Journal Of Urology 2016, 195: e496. DOI: 10.1016/j.juro.2016.02.1652.
- Rotker K, Brito J, Edmund L, Matoso A, Renzulli J. PD03-05 UPSTAGING IN RADICAL PROSTATECTOMY IN THE POST-PSA ERA: AN EFFECT OF DELAYED DIAGNOSIS OR BETTER PATIENT SELECTION? Journal Of Urology 2016, 195: e57-e58. DOI: 10.1016/j.juro.2016.02.2093.
- Leone A, Diorio G, Mega A, Renzulli J. Communication on the Impact of Multidisciplinary Care in a Large Volume Robot-Assisted Radical Prostatectomy Program: A Paradoxical Stage Migration toward More Aggressive Disease. Journal Of Medical & Surgical Pathology 2016, 1: 1-2. DOI: 10.4172/2472-4971.1000123.
- Mega A, Renzulli J, Quesenberry P, Chatterjee D. Reversal of castrate resistant prostate cancer by extracellular vesicle therapy. Journal Of Clinical Oncology 2015, 33: e16111-e16111. DOI: 10.1200/jco.2015.33.15_suppl.e16111.
- Vigneswaran H, Hwang K, Renzulli J, Chan P. MP25-10 ETIOLOGY OF SYMPTOMATIC URETHRITIS IN MEN ACCORDING TO SEXUAL BEHAVIORS. Journal Of Urology 2015, 193: e288-e289. DOI: 10.1016/j.juro.2015.02.1213.
- Leone A, Gershman B, Rotker K, Butler C, Fantasia J, Afiadata A, Li J, Sebo T, Zhou A, Jiang Z, Amin A, Mega A, Schiff S, Pareek G, Golijanin D, Yates J, Karnes R, Renzulli J. MP14-17 IMMEDIATE REPEAT BIOPSY IS NOT NECESSARY IN PATIENTS WITH ATYPICAL SMALL ACINAR PROLIFERATION (ASAP): A MULTI-INSTITUTIONAL REVIEW. Journal Of Urology 2015, 193: e157. DOI: 10.1016/j.juro.2015.02.879.
- Leone A, Turini G, Brito J, Tran T, Renzulli J, Pareek G, Golijanin D. MP57-16 ANTIPLATELET/ANTICOAGULATION THERAPY DOES NOT INCREASE IMMEDIATE COMPLICATIONS IN PATIENTS UNDERGOING ROBOTIC PARTIAL NEPHRECTOMY (RPN). Journal Of Urology 2015, 193: e695-e696. DOI: 10.1016/j.juro.2015.02.2004.
- Nadeem O, Mega A, Keller E, Renzulli J, Quesenberry P, Chatterjee D. Extracellular vesicle-mediated reversal of taxane resistance and the malignant phenotype in prostate cancer. Journal Of Clinical Oncology 2014, 32: e16028-e16028. DOI: 10.1200/jco.2014.32.15_suppl.e16028.
- Butler C, Rotker K, Leone A, Amin A, Schiff S, Pareek G, Golijanin D, Renzulli J. Is immediate repeat biopsy necessary for men with atypical small acinar proliferation? Journal Of Clinical Oncology 2014, 32: e16049-e16049. DOI: 10.1200/jco.2014.32.15_suppl.e16049.
- Leone A, Loverme W, Tran T, Elsamra S, Dupuy D, Renzulli J, Pareek G, Golijanin D. MP54-10 MEDIAL PERINEPHRIC FAT, POSTERIOR ABDOMINAL, AND LATERAL ABDOMINAL WALL FAT ARE CORRELATED WITH COMPLICATIONS IN ROBOTIC ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMIES (RALPN). Journal Of Urology 2014, 191: e575-e576. DOI: 10.1016/j.juro.2014.02.1599.
- Dai J, Hwang K, Mermel L, Pareek G, Schiff S, Golijanin D, Renzulli J. MP16-13 RECTAL SWAB CULTURE-DIRECTED ANTIMICROBIAL PROPHYLAXIS FOR PROSTATE BIOPSY IS ASSOCIATED WITH A LOWER RISK OF INFECTIOUS COMPLICATIONS. Journal Of Urology 2014, 191: e158. DOI: 10.1016/j.juro.2014.02.586.
- Cross-Knorr S, Renzulli J, Pantazatos D, Panagopoulos K, Del Tatto M, Goldstein L, Quesenberry P, Chatterjee D. 801 REVERSAL OF CHEMOSENSITIVITY AND INDUCTION OF CELL MALIGNANCY OF A NON-MALIGNANT PROSTATE CANCER CELL LINE UPON MICROVESICLE EXPOSURE. Journal Of Urology 2013, 189: e330. DOI: 10.1016/j.juro.2013.02.365.
- Maddox M, Renzulli J, Golijanin D, Elsamra S, Somerville M, Cohen S. 1943 PROSTATE SPECIFIC ANTIGEN DENSITY VELOCITY ON DUTASTERIDE HELPS PREDICT NEGATIVE PROSTATE BIOPSY: ANALYSIS OF THE REDUCE TRIAL. Journal Of Urology 2013, 189: e796-e797. DOI: 10.1016/j.juro.2013.02.2362.
- Bishop K, Layton J, Furman M, Maddox M, Grand D, Renzulli J, Mega A. 1248 PROSTATE MRI TO EVALUATE EXTRA-CAPSULAR EXTENSION AND SEMINAL VESICLE INVASION IN PROSTATE CANCER IN A COMMUNITY SETTING. Journal Of Urology 2013, 189: e510-e511. DOI: 10.1016/j.juro.2013.02.2602.
- Maddox M, Pareek G, Thavaseelan S, Mega A, Renzulli J. 1213 CONTEMPORARY ANALYSIS OF POST-PROSTATECTOMY SPECIMENS IN A LARGE VOLUME ROBOTIC PROSTATECTOMY PROGRAM: A PARADOXICAL STAGE MIGRATION TOWARD MORE AGGRESSIVE DISEASE. Journal Of Urology 2013, 189: e497. DOI: 10.1016/j.juro.2013.02.2567.
- Maddox M, Layton J, Taber A, Mega A, Renzulli J. 766 FEASIBILITY OF RADICAL PROSTATECTOMY FOLLOWING NEOADJUVANT IXABEPILONE FOR HIGH-RISK PROSTATE CANCER: A PHASE II CLINICAL TRIAL. Journal Of Urology 2013, 189: e314-e315. DOI: 10.1016/j.juro.2013.02.330.
- Layton J, Plette A, Renzulli J, Miller E, Safran H, Mega A. The impact of neoadjuvant weekly ixabepilone for high-risk prostate cancer: A phase I/II clinical trial. Journal Of Clinical Oncology 2012, 30: 158-158. DOI: 10.1200/jco.2012.30.5_suppl.158.
- Renzulli J, Dooner G, Owens C, Colvin G, Dooner M, Del Tatto M, Goldstein L, Quesenberry P. Microvesicular-mediated gene transfer of prostate tumor markers. Journal Of Clinical Oncology 2009, 27: e16076-e16076. DOI: 10.1200/jco.2009.27.15_suppl.e16076.
- Lasser M, Renzulli J, Turini G, Haleblian G, Sax H, Pareek G. A BLINDED PROSPECTIVE REPORT OF COMPLICATIONS ASSOCIATED WITH ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY. Journal Of Urology 2009, 181: 578. DOI: 10.1016/s0022-5347(09)61629-3.
- Renzulli J, Dooner G, Owens C, Colvin G, Quesenberry P. MICROVESICULAR-MEDIATED GENE TRANSFER OF PROSTATE TUMOR MARKERS. Journal Of Urology 2009, 181: 187. DOI: 10.1016/s0022-5347(09)60538-3.
- Yates J, Renzulli J, Iannotti H, Haleblian G, Pareek G. CONVERTING FROM OPEN TO ROBOTIC PROSTATECTOMY: INSTITUTIONAL IMPACT ON NUMBER OF PELVIC LYMPH NODES RETRIEVED DURING ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALRP). Journal Of Urology 2008, 179: 50. DOI: 10.1016/s0022-5347(08)60150-0.
- Gelardi N, Rapoza R, Renzulli J, Cowett R. Insulin resistance and glucose transporter expression during the euglycemic hyperinsulinemic clamp in the lamb. American Journal Of Physiology 1999, 277: e1142-e1149. PMID: 10600805, DOI: 10.1152/ajpendo.1999.277.6.e1142.
Departments and Programs
Locations
1
1 of 3
- Westerly Hospital35 Wells StreetSte Yale UrologyWesterly, RI 02891
- Yale UrologyLawrence + Memorial Hospital365 Montauk Avenue, Fl 2nd Floor Ste Suite 2.013New London, CT 06320
- Yale Urology176 Toll Gate RoadSte Suite 301Warwick, RI 02886
Biography
Joseph F. Renzulli II MD, FACS, is a Yale Medicine urologist who has expertise in robotic-assisted and laparoscopic surgeries for treating urologic cancers such as prostate, bladder, and kidney cancer.
“The best part of my job is being able to offer patients cutting-edge surgical therapies right here in their own community,” Dr. Renzulli says, “so that they do not have to travel to distant medical centers and be away from their loved ones during their most stressful times.” For him, medicine is a calling. “Being able to help people in their most vulnerable times is something that I have always seen as an amazing responsibility, and I am privileged to be able to care for them,” he says. After a cancer diagnosis, Dr. Renzulli develops individualized treatment plans for his patients, which may include helping them find and enroll in open clinical trials. He also tries to ease anxiety.
“I tell patients to let me do the worrying for them. I have seen their situation before and can take care of it for them,” he says.
Titles
- Associate Professor of Urology
- Chief of Urology at Lawrence + Memorial Hospital, Urology, Lawrence + Memorial Hospital
- Chief of Urology at Westerly Hospital, Urology, Westerly Hospital
Education & Training
- Chief ResidentYale School of Medicine (2006)
- ResidentYale School of Medicine (2005)
- InternshipYale School of Medicine (2002)
- MDBoston University School of Medicine (2001)
- BABoston University, Biology (1997)
Additional Information
Board Certifications
- AB of Urology, Urology (2008)
Publications
- Ajjawi I, Sprenkle P, Renzulli J, Leapman M. Re-evaluating the Role of Locoregional Therapy in Metastatic Prostate Cancer: A Review of Current Evidence and Evolving Clinical Approaches. Urologic Clinics Of North America 2026 DOI: 10.1016/j.ucl.2026.02.002.
- Smani S, DuBois J, Ajjawi I, Sohoni N, Choksi A, Lokeshwar S, Kim I, Renzulli J. Advances in Current Treatment Paradigms for Metastatic Hormone-Sensitive Prostate Cancer. Journal Of Clinical Medicine 2025, 14: 2565. PMID: 40283395, PMCID: PMC12028174, DOI: 10.3390/jcm14082565.
- Kinnaird A, Luger F, Cash H, Ghai S, Urdaneta-Salegui LF, Pavlovich CP, Brito J, Shore ND, Struck JP, Schostak M, Harland N, Rodriguez-Socarrás M, Brisbane WG, Lughezzani G, Toledano H, Ouertani MS, Macek P, Fung C, Tu W, Gusenleitner A, Günzel K, Incze PF, George AK, Pereira JG, Jansen R, Renzulli J 2nd, Klotz L, OPTIMUM Investigators. Microultrasonography-Guided vs MRI-Guided Biopsy for Prostate Cancer Diagnosis: The OPTIMUM Randomized Clinical Trial. JAMA 2025 PMID: 40121537, DOI: 10.1001/jama.2025.3579.
- Khajir G, Webb L, Lokeshwar S, Diaz G, Anderson T, Choksi A, Zhao J, Leapman M, Sprenkle P, Renzulli J. Diagnostic performance of high-resolution micro-ultrasound and conventional ultrasound in fusion biopsy for clinically significant prostate cancer detection. Urologic Oncology Seminars And Original Investigations 2025, 43: 399.e1-399.e8. PMID: 40121104, DOI: 10.1016/j.urolonc.2025.03.006.
- GC6 – Micro-ultrasound-guided versus MRI-guided biopsy for prostate cancer diagnosis (OPTIMUM trial)Klotz L, Luger F, Cash H, Schostak M, Ghai S, Pavlovich C, Urdaneta-Salegui L, Struck J, Renzulli J, Shore N, Gomez-Sancha F, Harland N, Brisbane W, Lughezzani G, Toledano H, Ouertani S, Macek P, Fung C, Gusenleitner A, Tu W, Kinnaird A. GC6 – Micro-ultrasound-guided versus MRI-guided biopsy for prostate cancer diagnosis (OPTIMUM trial). European Urology 2025, 87: s1794-s1795. DOI: 10.1016/j.eururo.2025.09.4123.
- Kim I, Leapman M, Kim M, Rahman S, Sprenkle P, Renzulli J, Brito J, Hyams E, Kim J, Pareek G, Kim I. Radical prostatectomy is associated with favorable outcomes in patients over 80 years old. American Journal Of Clinical And Experimental Urology 2025, 13: 33-42. PMID: 40124572, PMCID: PMC11928824, DOI: 10.62347/nkgs2301.
- Lokeshwar S, Choksi A, Smani S, Kong V, Sundaresan V, Sutherland R, Brito J, Renzulli J, Sprenkle P, Leapman M. Pathologic prostate cancer grade concordance among high-resolution micro-ultrasound, systematic transrectal ultrasound and MRI fusion biopsy. Urologic Oncology Seminars And Original Investigations 2024, 43: 336.e13-336.e20. PMID: 39521675, DOI: 10.1016/j.urolonc.2024.10.018.
- Smani S, Novosel M, Sutherland R, Jeong F, Jalfon M, Marks V, Rajwa P, Nolazco J, Washington S, Renzulli J, Sprenkle P, Kim I, Leapman M. Association between sociodemographic factors and diagnosis of lethal prostate cancer in early life. Urologic Oncology Seminars And Original Investigations 2023, 42: 28.e9-28.e20. PMID: 38161105, DOI: 10.1016/j.urolonc.2023.10.005.
- Shore N, Renzulli J, Fleshner N, Hollowell C, Vourganti S, Silberstein J, Siddiqui R, Hairston J, Elsouda D, Russell D, Cooperberg M, Tomlins S. MP62-17 ENZALUTAMIDE IN PATIENTS WITH LOCALIZED PROSTATE CANCER UNDERGOING ACTIVE SURVEILLANCE: ENACT. Journal Of Urology 2021, 206: e1099-e1099. DOI: 10.1097/ju.0000000000002102.17.
- Ross A, Armstrong A, Pieczonka C, Bailen J, Tutrone R, Cooperberg M, Pavlovich C, Renzulli J, Haynes H, Sheikh N, Shore N. A comparison of sipuleucel-T (sip-T) product parameters from two phase III studies: PROVENT in active surveillance prostate cancer and IMPACT in metastatic castrate-resistant prostate cancer (mCRPC). Journal Of Clinical Oncology 2020, 38: 321-321. DOI: 10.1200/jco.2020.38.6_suppl.321.
- Pereira J, Gershman B, Renzulli J. PD52-03 THE ASSOCIATION OF EDUCATION LEVEL WITH THE UTILIZATION OF SHARED DECISION MAKING IN PROSTATE CANCER SCREENING. Journal Of Urology 2018, 199: e981-e982. DOI: 10.1016/j.juro.2018.02.2355.
- Pereira J, Pareek G, Golijanin D, Renzulli J, Gershman B. MP14-05 THE ASSOCIATION OF AGE WITH PERIOPERATIVE MORBIDITY AND MORTALITY AMONG PATIENTS UNDERGOING RADICAL PROSTATECTOMY. Journal Of Urology 2017, 197: e163-e164. DOI: 10.1016/j.juro.2017.02.469.
- Pereira J, Shillan H, Tucci C, Pareek G, Golijanin D, Gershman B, Renzulli J. MP97-13 ASSOCIATION OF EXTENDED PELVIC LYMPH NODE DISSECTION WITH THROMBOEMBOLIC EVENTS AND LYMPHOCELE FORMATION AMONG MEN UNDERGOING ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY WITH PELVIC LYMPH NODE DISSECTION. Journal Of Urology 2017, 197: e1308. DOI: 10.1016/j.juro.2017.02.3057.
- Turini G, Renzulli J. MP92-19 NOVEL, NONTOXIC SKIN CARE FORMULATION ASSOCIATED WITH LOWER CAUTI RATES FOR HIGH-RISK ICU, NEURO, C-V AND TRAUMA PATIENTS WHEN USED FOR FOLEY CATHETER INSERTION AND MAINTENANCE. Journal Of Urology 2017, 197: e1235. DOI: 10.1016/j.juro.2017.02.2880.
- Pereira J, Renzulli J, Pareek G, Moreira D, Golijanin D, Gershman B. 781 Perioperative morbidity of open versus minimally invasive partial nephrectomy: A contemporary analysis of the National Surgical Quality Improvement Program (NSQIP). European Urology Open Science 2017, 16: e1352-e1353. DOI: 10.1016/s1569-9056(17)30834-5.
- Turini G, Clark M, Machan J, Tucci C, Renzulli J. The Role of a Standardized Clinical Care Pathway in Patient Satisfaction and Quality of Life Outcomes after Robotic Assisted Laparoscopic Radical Prostatectomy. Urology Practice 2016, 4: 232-238. PMID: 37592643, DOI: 10.1016/j.urpr.2016.06.006.
- Leone A, Diorio G, Brito J, Zargar K, Pareek G, Renzulli J, Dickinson S, Amin A, Sexton W, Spiess P, Poch M, Golijanin D. Presence and percentage of type 2 papillary RCC in mixed (type 1 and type 2) papillary renal cell carcinoma does not portend worse prognosis in patients treated by partial/radical nephrectomy in non-metastatic disease. Journal Of Clinical Oncology 2016, 34: e16126-e16126. DOI: 10.1200/jco.2016.34.15_suppl.e16126.
- Turini G, Gjelsvik A, Golijanin D, Pareek G, Renzulli J. PD09-07 THE ROLE OF PATIENT RACE AND ETHNICITY IN PREDICTING PHYSICIAN RECOMMENDATION OF PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING. Journal Of Urology 2016, 195: e236. DOI: 10.1016/j.juro.2016.02.2902.
- Turini G, Clark M, Tucci C, Machan J, Golijanin D, Pareek G, Renzulli J. MP08-05 REDUCED LENGTH OF STAY AND READMISSION RATES USING A STANDARDIZED CLINICAL CARE PATHWAY FOLLOWING ROBOTIC PROSTATECTOMY. Journal Of Urology 2016, 195: e86. DOI: 10.1016/j.juro.2016.02.2250.
- Brito J, Rotker K, Lepe M, Quddus M, Manna P, Epstein J, Matoso A, Renzulli J. MP36-18 HIGH-RISK HPV SUBTYPES IN SQUAMOUS CELL CARCINOMA OF THE SCROTUM. Journal Of Urology 2016, 195: e496. DOI: 10.1016/j.juro.2016.02.1652.
- Rotker K, Brito J, Edmund L, Matoso A, Renzulli J. PD03-05 UPSTAGING IN RADICAL PROSTATECTOMY IN THE POST-PSA ERA: AN EFFECT OF DELAYED DIAGNOSIS OR BETTER PATIENT SELECTION? Journal Of Urology 2016, 195: e57-e58. DOI: 10.1016/j.juro.2016.02.2093.
- Leone A, Diorio G, Mega A, Renzulli J. Communication on the Impact of Multidisciplinary Care in a Large Volume Robot-Assisted Radical Prostatectomy Program: A Paradoxical Stage Migration toward More Aggressive Disease. Journal Of Medical & Surgical Pathology 2016, 1: 1-2. DOI: 10.4172/2472-4971.1000123.
- Mega A, Renzulli J, Quesenberry P, Chatterjee D. Reversal of castrate resistant prostate cancer by extracellular vesicle therapy. Journal Of Clinical Oncology 2015, 33: e16111-e16111. DOI: 10.1200/jco.2015.33.15_suppl.e16111.
- Vigneswaran H, Hwang K, Renzulli J, Chan P. MP25-10 ETIOLOGY OF SYMPTOMATIC URETHRITIS IN MEN ACCORDING TO SEXUAL BEHAVIORS. Journal Of Urology 2015, 193: e288-e289. DOI: 10.1016/j.juro.2015.02.1213.
- Leone A, Gershman B, Rotker K, Butler C, Fantasia J, Afiadata A, Li J, Sebo T, Zhou A, Jiang Z, Amin A, Mega A, Schiff S, Pareek G, Golijanin D, Yates J, Karnes R, Renzulli J. MP14-17 IMMEDIATE REPEAT BIOPSY IS NOT NECESSARY IN PATIENTS WITH ATYPICAL SMALL ACINAR PROLIFERATION (ASAP): A MULTI-INSTITUTIONAL REVIEW. Journal Of Urology 2015, 193: e157. DOI: 10.1016/j.juro.2015.02.879.
- Leone A, Turini G, Brito J, Tran T, Renzulli J, Pareek G, Golijanin D. MP57-16 ANTIPLATELET/ANTICOAGULATION THERAPY DOES NOT INCREASE IMMEDIATE COMPLICATIONS IN PATIENTS UNDERGOING ROBOTIC PARTIAL NEPHRECTOMY (RPN). Journal Of Urology 2015, 193: e695-e696. DOI: 10.1016/j.juro.2015.02.2004.
- Nadeem O, Mega A, Keller E, Renzulli J, Quesenberry P, Chatterjee D. Extracellular vesicle-mediated reversal of taxane resistance and the malignant phenotype in prostate cancer. Journal Of Clinical Oncology 2014, 32: e16028-e16028. DOI: 10.1200/jco.2014.32.15_suppl.e16028.
- Butler C, Rotker K, Leone A, Amin A, Schiff S, Pareek G, Golijanin D, Renzulli J. Is immediate repeat biopsy necessary for men with atypical small acinar proliferation? Journal Of Clinical Oncology 2014, 32: e16049-e16049. DOI: 10.1200/jco.2014.32.15_suppl.e16049.
- Leone A, Loverme W, Tran T, Elsamra S, Dupuy D, Renzulli J, Pareek G, Golijanin D. MP54-10 MEDIAL PERINEPHRIC FAT, POSTERIOR ABDOMINAL, AND LATERAL ABDOMINAL WALL FAT ARE CORRELATED WITH COMPLICATIONS IN ROBOTIC ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMIES (RALPN). Journal Of Urology 2014, 191: e575-e576. DOI: 10.1016/j.juro.2014.02.1599.
- Dai J, Hwang K, Mermel L, Pareek G, Schiff S, Golijanin D, Renzulli J. MP16-13 RECTAL SWAB CULTURE-DIRECTED ANTIMICROBIAL PROPHYLAXIS FOR PROSTATE BIOPSY IS ASSOCIATED WITH A LOWER RISK OF INFECTIOUS COMPLICATIONS. Journal Of Urology 2014, 191: e158. DOI: 10.1016/j.juro.2014.02.586.
- Cross-Knorr S, Renzulli J, Pantazatos D, Panagopoulos K, Del Tatto M, Goldstein L, Quesenberry P, Chatterjee D. 801 REVERSAL OF CHEMOSENSITIVITY AND INDUCTION OF CELL MALIGNANCY OF A NON-MALIGNANT PROSTATE CANCER CELL LINE UPON MICROVESICLE EXPOSURE. Journal Of Urology 2013, 189: e330. DOI: 10.1016/j.juro.2013.02.365.
- Maddox M, Renzulli J, Golijanin D, Elsamra S, Somerville M, Cohen S. 1943 PROSTATE SPECIFIC ANTIGEN DENSITY VELOCITY ON DUTASTERIDE HELPS PREDICT NEGATIVE PROSTATE BIOPSY: ANALYSIS OF THE REDUCE TRIAL. Journal Of Urology 2013, 189: e796-e797. DOI: 10.1016/j.juro.2013.02.2362.
- Bishop K, Layton J, Furman M, Maddox M, Grand D, Renzulli J, Mega A. 1248 PROSTATE MRI TO EVALUATE EXTRA-CAPSULAR EXTENSION AND SEMINAL VESICLE INVASION IN PROSTATE CANCER IN A COMMUNITY SETTING. Journal Of Urology 2013, 189: e510-e511. DOI: 10.1016/j.juro.2013.02.2602.
- Maddox M, Pareek G, Thavaseelan S, Mega A, Renzulli J. 1213 CONTEMPORARY ANALYSIS OF POST-PROSTATECTOMY SPECIMENS IN A LARGE VOLUME ROBOTIC PROSTATECTOMY PROGRAM: A PARADOXICAL STAGE MIGRATION TOWARD MORE AGGRESSIVE DISEASE. Journal Of Urology 2013, 189: e497. DOI: 10.1016/j.juro.2013.02.2567.
- Maddox M, Layton J, Taber A, Mega A, Renzulli J. 766 FEASIBILITY OF RADICAL PROSTATECTOMY FOLLOWING NEOADJUVANT IXABEPILONE FOR HIGH-RISK PROSTATE CANCER: A PHASE II CLINICAL TRIAL. Journal Of Urology 2013, 189: e314-e315. DOI: 10.1016/j.juro.2013.02.330.
- Layton J, Plette A, Renzulli J, Miller E, Safran H, Mega A. The impact of neoadjuvant weekly ixabepilone for high-risk prostate cancer: A phase I/II clinical trial. Journal Of Clinical Oncology 2012, 30: 158-158. DOI: 10.1200/jco.2012.30.5_suppl.158.
- Renzulli J, Dooner G, Owens C, Colvin G, Dooner M, Del Tatto M, Goldstein L, Quesenberry P. Microvesicular-mediated gene transfer of prostate tumor markers. Journal Of Clinical Oncology 2009, 27: e16076-e16076. DOI: 10.1200/jco.2009.27.15_suppl.e16076.
- Lasser M, Renzulli J, Turini G, Haleblian G, Sax H, Pareek G. A BLINDED PROSPECTIVE REPORT OF COMPLICATIONS ASSOCIATED WITH ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY. Journal Of Urology 2009, 181: 578. DOI: 10.1016/s0022-5347(09)61629-3.
- Renzulli J, Dooner G, Owens C, Colvin G, Quesenberry P. MICROVESICULAR-MEDIATED GENE TRANSFER OF PROSTATE TUMOR MARKERS. Journal Of Urology 2009, 181: 187. DOI: 10.1016/s0022-5347(09)60538-3.
- Yates J, Renzulli J, Iannotti H, Haleblian G, Pareek G. CONVERTING FROM OPEN TO ROBOTIC PROSTATECTOMY: INSTITUTIONAL IMPACT ON NUMBER OF PELVIC LYMPH NODES RETRIEVED DURING ROBOTIC-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALRP). Journal Of Urology 2008, 179: 50. DOI: 10.1016/s0022-5347(08)60150-0.
- Gelardi N, Rapoza R, Renzulli J, Cowett R. Insulin resistance and glucose transporter expression during the euglycemic hyperinsulinemic clamp in the lamb. American Journal Of Physiology 1999, 277: e1142-e1149. PMID: 10600805, DOI: 10.1152/ajpendo.1999.277.6.e1142.
Departments and Programs
Locations
1
1 of 3
- Westerly Hospital35 Wells StreetSte Yale UrologyWesterly, RI 02891
- Yale UrologyLawrence + Memorial Hospital365 Montauk Avenue, Fl 2nd Floor Ste Suite 2.013New London, CT 06320
- Yale Urology176 Toll Gate RoadSte Suite 301Warwick, RI 02886
1
1 of 3
- Westerly Hospital35 Wells StreetSte Yale UrologyWesterly, RI 02891
- Yale UrologyLawrence + Memorial Hospital365 Montauk Avenue, Fl 2nd Floor Ste Suite 2.013New London, CT 06320
- Yale Urology176 Toll Gate RoadSte Suite 301Warwick, RI 02886